Autolus Therapeutics plc American Depositary Share

AUTLNASDAQ • USD
1.40 USD
↘ 0.02 (1.42%)🔴AT CLOSE (AS OF 07:57 PM EDT)
🔴Market: CLOSED
Open?$1.40
High?$1.43
Low?$1.38
Prev. Close?$1.41
Volume?1.3M
Avg. Volume?N/A
VWAP?$1.40
Bid / Ask
Bid?$1.38 × 500
Ask?$1.42 × 100.0K
Spread?$0.04
Midpoint?$1.40
Valuation & Ratios
Market Cap?375.3M
Shares Out?266.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Employees
752
Market Cap
375.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.autolus.com
Listed
2018-06-22
Address
THE MEDIAWORKS
LONDON, X0 W12 7FP
Phone: 44 20 3829 6230
MarketsMoversWatchlist